|1.||Corthésy, Blaise: 9 articles (11/2013 - 02/2003)|
|2.||Liberati, David M: 8 articles (09/2014 - 10/2003)|
|3.||Diebel, Lawrence N: 8 articles (09/2014 - 10/2003)|
|4.||Brandtzaeg, Per: 7 articles (09/2011 - 04/2003)|
|5.||Fujihashi, Kohtaro: 6 articles (01/2015 - 09/2010)|
|6.||Kiyono, Hiroshi: 5 articles (01/2015 - 02/2007)|
|7.||Kido, Hiroshi: 5 articles (11/2012 - 10/2008)|
|8.||Gleeson, Michael: 4 articles (01/2016 - 09/2005)|
|9.||Sawa, Mitsuru: 4 articles (12/2013 - 04/2006)|
|10.||Brandtzaeg, P: 4 articles (03/2013 - 01/2003)|
10/01/2004 - "Although secretory IgA was found to be important for protection against nasal carriage, it does not appear to have a crucial role in immunity to systemic pneumococcus infection, because both vaccinated wild-type and pIgR(-/-) mice were fully protected from lethal systemic infection by serotype 3 pneumococci. "
05/15/2001 - "These results underscore the important role of secretory IgA in designing strategies for mucosal protection against HIV-1 infection."
12/01/1986 - "Secretory IgA antibody may be important in protection against respiratory viral infections, and the concept of a common mucosal immune system offers the theoretical basis for the convenient stimulation of this antibody. "
07/01/1977 - "Thisfinding supports the hypothesis that the responsiveness of the host in the production of secretory IgA during infection is important in protection against mucosal infections."
08/01/1995 - "Immunization therapy caused a significant reduction in the frequency of infection and an increase in urinary sIgA SC, while in the nonvaccinated group the values remained constant."
05/11/2010 - "Thus, MucoRice-CTB is an effective long-term cold chain-free oral vaccine that induces CTB-specific SIgA-mediated longstanding protection against V. cholerae- or LT-ETEC-induced diarrhea."
01/01/2012 - "This model allows not only studying the molecular pathogenesis of Salmonella diarrhea but also is ideally suited for analyzing innate defenses, microbe handling by mucosal phagocytes, adaptive secretory immunoglobulin A responses, probing microbiota function, and homeostatic microbiota-host interactions. "
09/01/2002 - "Patients with diarrhea due to noninvasive ST/LT ETEC and LT ETEC commonly produce a specific sIgA antibody response early in the illness. "
02/01/2001 - "In order to understand the role played by Aeromonas strains as gastrointestinal infectious agents, the sIgA response in fecal specimens obtained from patients with naturally acquired Aeromonas diarrhea was examined. "
05/01/2000 - "Ten paired samples from 10 patients with diarrhea caused by EAEC were examined for the presence of specific sIgA by dot blot and Western blot immunoassays. "
02/01/1989 - "For example the importance of antibacterial as well as antitoxin local secretory IgA, for protection against cholera, has been underlined in several studies. "
09/01/2001 - "Women with cholera did not develop sIgA anti-CtxB responses in serum. "
01/01/1989 - "Parenteral cholera vaccination enhanced both serum and SIgA milk antibody response. "
01/01/1986 - "The effects of acupuncture on the production of anti-Vibrio cholerae in serum of the immunized mice can not be found, but produced positive effects in small intestine both on production of SIgA and antagonism to cholera. "
11/01/1980 - "The results suggest a significant difference in the capacity of parenterally administered cholera vaccine to stimulate SIgA antibody formation in naturally primed and nonprimed individuals."
|4.||Human Influenza (Influenza)
11/01/2009 - "CAM boosted the nasopharyngeal mucosal immune response in children presenting with influenza A, even in those treated with OSV who had low production of mucosal anti-viral sIgA, and alleviated the symptoms of influenza."
01/01/2001 - "Impairment of mucosal immunity by parenteral nutrition: depressed nasotracheal influenza-specific secretory IgA levels and transport in parenterally fed mice."
02/01/2009 - "In the case of mucosally acquired acute respiratory infection such as influenza, mucosal immunity induced by natural infection plays important role in protection against the infection, as mucosal secretory IgA antibody plays an important role in cross-protection. "
01/01/2003 - "However, infection models in knockout mice support the notion that SIgA exerts a decisive role in protection and cross-protection against influenza."
09/01/1993 - "The resulting comparative data suggest that determination by EIA of specific secretory IgA in the saliva may be recommended as an independent test for large-scale influenza diagnosis, evaluation of the immune status of people, and trials of influenza vaccines. "
|5.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/2013 - "The high concentration of human secretory IgA (hsIgA) in human colostrum strongly suggests that it should play an important role in the passive immune protection against gastrointestinal and respiratory infections. "
10/01/1996 - "The aim of the present study was to determine whether sIgA increases during relaxation in children aged between 8 and 12 years with recurrent upper respiratory tract infections. "
01/01/2015 - "Elite athletes frequently report symptoms associated with upper respiratory tract infections (URTI) during periods of heavy training and competition that may be due to alterations in mucosal immunity, particularly reductions in secretory immunoglobulin A. "
12/01/2002 - "Dietary restriction, consumption of alcohol, body mass loss, occurrence of upper respiratory tract infection, and negative emotions were negatively associated with SIgA:Alb. "
12/01/2001 - "The effects of stress management on symptoms of upper respiratory tract infection, secretory immunoglobulin A, and mood in young adults."
|1.||Immunoglobulin A (IgA)
|2.||Secretory Immunoglobulin A (SIgA)
|4.||Immunoglobulin G (IgG)
|5.||Immunoglobulin M (IgM)
|8.||DNA (Deoxyribonucleic Acid)
|2.||Total Parenteral Nutrition
|3.||Prostheses and Implants (Prosthesis)
|5.||Drug Therapy (Chemotherapy)